These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 32584596)

  • 1. The Role of the TL1A/DR3 Axis in the Activation of Group 2 Innate Lymphoid Cells in Subjects with Eosinophilic Asthma.
    Machida K; Aw M; Salter BMA; Ju X; Mukherjee M; Gauvreau GM; O'Byrne PM; Nair P; Sehmi R
    Am J Respir Crit Care Med; 2020 Oct; 202(8):1105-1114. PubMed ID: 32584596
    [No Abstract]   [Full Text] [Related]  

  • 2. The TNF-family ligand TL1A and its receptor DR3 promote T cell-mediated allergic immunopathology by enhancing differentiation and pathogenicity of IL-9-producing T cells.
    Richard AC; Tan C; Hawley ET; Gomez-Rodriguez J; Goswami R; Yang XP; Cruz AC; Penumetcha P; Hayes ET; Pelletier M; Gabay O; Walsh M; Ferdinand JR; Keane-Myers A; Choi Y; O'Shea JJ; Al-Shamkhani A; Kaplan MH; Gery I; Siegel RM; Meylan F
    J Immunol; 2015 Apr; 194(8):3567-82. PubMed ID: 25786692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromedin-U Mediates Rapid Activation of Airway Group 2 Innate Lymphoid Cells in Mild Asthma.
    Ju X; Nagashima A; Dvorkin-Gheva A; Wattie J; Howie K; Whetstone C; Ranjbar M; Cusack R; Ditta R; Paré G; Satia I; O'Byrne PM; Gauvreau GM; Sehmi R
    Am J Respir Crit Care Med; 2024 Sep; 210(6):755-765. PubMed ID: 38598774
    [No Abstract]   [Full Text] [Related]  

  • 4. Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia.
    Smith SG; Chen R; Kjarsgaard M; Huang C; Oliveria JP; O'Byrne PM; Gauvreau GM; Boulet LP; Lemiere C; Martin J; Nair P; Sehmi R
    J Allergy Clin Immunol; 2016 Jan; 137(1):75-86.e8. PubMed ID: 26194544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen-induced Increases in Sputum Levels of Group 2 Innate Lymphoid Cells in Subjects with Asthma.
    Chen R; Smith SG; Salter B; El-Gammal A; Oliveria JP; Obminski C; Watson R; O'Byrne PM; Gauvreau GM; Sehmi R
    Am J Respir Crit Care Med; 2017 Sep; 196(6):700-712. PubMed ID: 28422515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF superfamily member TL1A elicits type 2 innate lymphoid cells at mucosal barriers.
    Yu X; Pappu R; Ramirez-Carrozzi V; Ota N; Caplazi P; Zhang J; Yan D; Xu M; Lee WP; Grogan JL
    Mucosal Immunol; 2014 May; 7(3):730-40. PubMed ID: 24220298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation.
    Meylan F; Richard AC; Siegel RM
    Immunol Rev; 2011 Nov; 244(1):188-96. PubMed ID: 22017439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human group3 innate lymphoid cells express DR3 and respond to TL1A with enhanced IL-22 production and IL-2-dependent proliferation.
    Ahn YO; Weeres MA; Neulen ML; Choi J; Kang SH; Heo DS; Bergerson R; Blazar BR; Miller JS; Verneris MR
    Eur J Immunol; 2015 Aug; 45(8):2335-42. PubMed ID: 26046454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor Necrosis Factor-like Cytokine TL1A and Its Receptors DR3 and DcR3: Important New Factors in Mucosal Homeostasis and Inflammation.
    Siakavellas SI; Bamias G
    Inflamm Bowel Dis; 2015 Oct; 21(10):2441-52. PubMed ID: 26099067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TL1A/DR3 Axis, A Key Target of TNF-a, Augments the Epithelial-Mesenchymal Transformation of Epithelial Cells in OVA-Induced Asthma.
    Zhang D; Yang H; Dong XL; Zhang JT; Liu XF; Pan Y; Zhang J; Xu JW; Wang ZH; Cui WJ; Dong L
    Front Immunol; 2022; 13():854995. PubMed ID: 35359966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay Between the IL-33/ST2 Axis and Bone Marrow ILC2s in Protease Allergen-Induced IL-5-Dependent Eosinophilia.
    Boberg E; Johansson K; Malmhäll C; Calvén J; Weidner J; Rådinger M
    Front Immunol; 2020; 11():1058. PubMed ID: 32582171
    [No Abstract]   [Full Text] [Related]  

  • 12. Steroid resistance of airway type 2 innate lymphoid cells from patients with severe asthma: The role of thymic stromal lymphopoietin.
    Liu S; Verma M; Michalec L; Liu W; Sripada A; Rollins D; Good J; Ito Y; Chu H; Gorska MM; Martin RJ; Alam R
    J Allergy Clin Immunol; 2018 Jan; 141(1):257-268.e6. PubMed ID: 28433687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.
    Cavallini C; Lovato O; Bertolaso A; Zoratti E; Malpeli G; Mimiola E; Tinelli M; Aprili F; Tecchio C; Perbellini O; Scarpa A; Zamò A; Cassatella MA; Pizzolo G; Scupoli MT
    Oncotarget; 2015 Oct; 6(31):32061-74. PubMed ID: 26393680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of type 2 innate lymphoid cells in eosinophilic asthma.
    Salter BM; Aw M; Sehmi R
    J Leukoc Biol; 2019 Oct; 106(4):889-901. PubMed ID: 31063647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions.
    Bamias G; Evangelou K; Vergou T; Tsimaratou K; Kaltsa G; Antoniou C; Kotsinas A; Kim S; Gorgoulis V; Stratigos AJ; Sfikakis PP
    Exp Dermatol; 2011 Sep; 20(9):725-31. PubMed ID: 21672030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-155 is a critical regulator of type 2 innate lymphoid cells and IL-33 signaling in experimental models of allergic airway inflammation.
    Johansson K; Malmhäll C; Ramos-Ramírez P; Rådinger M
    J Allergy Clin Immunol; 2017 Mar; 139(3):1007-1016.e9. PubMed ID: 27492144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TL1A (TNFSF15) and DR3 (TNFRSF25): A Co-stimulatory System of Cytokines With Diverse Functions in Gut Mucosal Immunity.
    Valatas V; Kolios G; Bamias G
    Front Immunol; 2019; 10():583. PubMed ID: 30972074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo.
    Jacob N; Kumagai K; Abraham JP; Shimodaira Y; Ye Y; Luu J; Blackwood AY; Castanon SL; Stamps DT; Thomas LS; Gonsky R; Shih DQ; Michelsen KS; Targan SR
    Sci Rep; 2020 Oct; 10(1):18189. PubMed ID: 33097818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting TL1A/DR3 Signaling Offers a Therapeutic Advantage to Neutralizing IL13/IL4Rα in Muco-Secretory Fibrotic Disorders.
    Steele H; Sachen K; McKnight AJ; Soloff R; Herro R
    Front Immunol; 2021; 12():692127. PubMed ID: 34305924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble TL1A is sufficient for activation of death receptor 3.
    Bittner S; Knoll G; Füllsack S; Kurz M; Wajant H; Ehrenschwender M
    FEBS J; 2016 Jan; 283(2):323-36. PubMed ID: 26509650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.